The expression of NLRP3 mRNA in the no BPG treatment subgroup was significantly higher than that in the BPG treatment subgroup at 21, 28, and 35 d post-infection (P < 0.05) (Fig. 2a). The gene discussed is NLRP3; the disease is infection.